Resona Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.6M | Buy |
52,548
+1,581
| +3% | +$199K | 0.03% | 435 |
|
|
2025
Q1 | $5.65M | Buy |
50,967
+1,129
| +2% | +$125K | 0.03% | 431 |
|
|
2024
Q4 | $6.81M | Sell |
49,838
-1,053
| -2% | -$144K | 0.04% | 380 |
|
|
2024
Q3 | $5.86M | Sell |
50,891
-221
| -0.4% | -$25.5K | 0.03% | 436 |
|
|
2024
Q2 | $7.02M | Buy |
51,112
+850
| +2% | +$117K | 0.04% | 366 |
|
|
2024
Q1 | $6.93M | Buy |
+50,262
| New | +$6.93M | 0.04% | 382 |
|